Get startedLog in
    Picture of Nxera Pharma logo

    4565 — Nxera Pharma News Story

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Nxera Pharma Says Receives $35 Mln From Neurocrine Biosciences Upon Positive Phase 2 Data For Partnered Schizophrenia Candidate NBI-1117568

    Picture of Nxera Pharma logoNxera Pharma
    02/09/2024 24:50
    Sept 1 (Reuters) - Nxera Pharma Co Ltd  4565.T :
    * NXERA PHARMA TO RECEIVE US$35 MILLION FROM NEUROCRINE
BIOSCIENCES UPON POSITIVE PHASE 2 DATA FOR PARTNERED
SCHIZOPHRENIA CANDIDATE NBI-1117568

Source text for Eikon:  ID:nGNX89Q16r 
Further company coverage:  4565.T 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Nxera Pharma

    See all news